advertisement
FDA approves artery plaque device
The U.S. Food and Drug Administration has approved a new device that helps doctors assess a person's risk of having a heart attack. The InfraReDx LipiScan NIR Catheter Imaging System works by inserting a catheter with a fiber-optic laser light into the artery and measuring the light reflected back from the artery wall. This helps doctors assess the fatty makeup of the plaque that has built up in the artery, a finding that helps the doctors find out a person's heart attack risk.
(U.S. News & World Report) UPDATED 04/29/2008Click here to read the full story
Conditions: | atherosclerosis - 406 Articles | heart disease - 622 Articles | high cholesterol - 483 Articles | stroke - 502 Articles
Helpful?
advertisement
